Planet 13 Holdings (PLNH) Income towards Parent Company (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Income towards Parent Company came in at -$8.1 million in Q1 2026, down 180.63% year-on-year from $10.0 million in Q1 2025, and down 215.53% on a QoQ basis from $7.0 million in Q4 2025.
Planet 13 Holdings (PLNH) Income towards Parent Company (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Income towards Parent Company data on file, last reported at -$8.1 million in Q1 2026.
- On a quarterly basis, Income towards Parent Company fell 180.63% year-over-year to -$8.1 million in Q1 2026; TTM through Mar 2026 was -$58.3 million, a 80.37% decrease from a year earlier, with the FY2025 full-year figure at -$52.3 million, down 46.87% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$8.1 million, down from $7.0 million in the prior quarter.
- Over the last five years, Income towards Parent Company for PLNH reached as high as $7.0 million in Q4 2025 and fell as low as -$46.3 million in Q3 2023.
- Historically, Income towards Parent Company has averaged -$13.6 million across 5 years, with a median of -$8.1 million in 2024.
- Across the five-year window, Income towards Parent Company sank 2136.41% in 2022 and surged 149.18% in 2025, its largest moves.
- Year by year, Income towards Parent Company stood at -$44.0 million in 2022, then surged by 67.6% to -$14.3 million in 2023, then gained by 0.07% to -$14.2 million in 2024, then jumped by 149.18% to $7.0 million in 2025, then plunged by 215.53% to -$8.1 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$8.1 million in Q1 2026, $7.0 million in Q4 2025, and -$44.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.42 Mn | 23.16 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.10 Mn |
| Dec 31, 2025 | 7.01 Mn |
| Sep 30, 2025 | -43.96 Mn |
| Jun 30, 2025 | -13.30 Mn |
| Mar 31, 2025 | -2.88 Mn |
| Dec 31, 2024 | -14.25 Mn |
| Sep 30, 2024 | -7.14 Mn |
| Jun 30, 2024 | -8.07 Mn |
| Mar 31, 2024 | -5.89 Mn |
| Dec 31, 2023 | -14.26 Mn |
| Sep 30, 2023 | -46.25 Mn |
| Jun 30, 2023 | -4.66 Mn |
| Mar 31, 2023 | -8.48 Mn |
| Dec 31, 2022 | -44.01 Mn |
| Sep 30, 2022 | -6.34 Mn |
| Jun 30, 2022 | -7.09 Mn |
| Mar 31, 2022 | -4.07 Mn |
| Dec 31, 2021 | -12.46 Mn |
| Sep 30, 2021 | 4.05 Mn |
| Jun 30, 2021 | 347,962.00 |